Oral vs. Injectable GLP-1s: Which Wins the Battle of the Bulge?

Did you hear the news? On April 1, the FDA approved yet another GLP-1 therapy, this time in pill form. It’s called Foundayo, and yo, no, this isn’t some April Fools’ joke.

That’s right… another alternative to Ozempic just entered the ring. And here’s the part your abdomen, thigh, or upper arm will appreciate: you don’t have to inject it into your subcutaneous fat anymore.

For a lot of my health coaching/functional medicine clients, that alone removes a major mental barrier.

But before you toss your injector pen in the trash (or finally agree to try one), let’s talk about what these drugs actually do, and whether swallowing a pill really beats the needle.

What GLP-1s Are (and How They Became a Cultural Phenomenon)

GLP-1 receptor agonists were not created by drug companies to be Hollywood’s favorite weight loss hack. Instead, these pedtide hormones (specifically, an incretin hormone composed of 30 or 31 amino acids, if you like to geek out on the science) were developed to treat type 2 diabetes.

Produced in the gut, GLP-1 regulates blood sugar and appetite by delaying the rate at which your stomach empties (helping you stay full longer), stimulating insulin, and suppressing glucagon (the flip solid of the coin to insulin; insulin stores sugar while glucagon breaks down stores sugar when blood sugar levels dip too low) and slowing gastric emptying

GLP-1 medications mimic the GLP-1 peptide. Researchers discovered that not only do GLP-1 medications help control blood sugar–essential for those living with type 2 diabetes–they also significantly reduce appetite, leading to weight loss.

And just like that, GLP-1s went from endocrine clinics to celebrity interviews, with all the ripple effects you’d expect: shortages, sky-high costs, and a whole lot of people chasing “effortless” fat loss.

Here are the names you’re most likely hearing in conversation right now:

• Ozempic (injectable) — semaglutide, FDA approved 2017 (type 2 diabetes)
• Wegovy (injectable) — semaglutide, FDA approved 2021 (weight loss)
• Zepbound (injectable) — tirzepatide, FDA approved 2023 (weight loss)
• Rybelsus (oral) — semaglutide, FDA approved 2019 (type 2 diabetes)
• Wegovy pill (oral) — semaglutide (oral formulation), FDA approved 2024 (weight loss)
• Foundayo (oral) — orforglipron, FDA approved 2026 (weight loss, Eli Lilly)

Ozempic and Wegovy still hog the GLP-1 spotlight. But they weren’t first to hit the market. Not even close. Five GLP-1 drugs came before it, starting in 2005, long before anyone was talking about “weight loss shots” at brunch. (The first GLP-1 drug was 2005’s Byetta [exenatide], which is rarely used today because it requires two injections per day!)

The New Oral GLP-1 Options

The newest addition is Foundayo, an oral GLP-1 from Eli Lilly, the same company behind Zepbound.

As NPR explains, what makes this one different is that it’s not a peptide like the injectable drugs. Instead, it uses a small-molecule compound (orforglipron) that mimics GLP-1 effects, but is easier for your body to absorb as a pill.

Some oral GLP-1s require you to take them on an empty stomach and then wait before eating. This one doesn’t come with the same strict timing rules, which, trust me, matters more than people think when you’re dealing with real life.

In clinical trials, patients taking the highest dose lost about 12.4% of their body weight over 72 weeks.

That’s significant. But how does that weight loss success stack against injectables?

Oral vs. Injectable: What Actually Matters in Real Life

On paper (research papers haha), injectables look like the winner.

They tend to produce greater weight loss. Some patients lose 15–20% or more of their body weight, depending on the medication and dose.

But here’s what doesn’t show up in clean clinical charts: human behavior.

Injectables are usually taken once a week. That’s convenient. But you still have to inject yourself. And while many patients get over that quickly, some never fully love it.

Oral medications, on the other hand, are taken daily. That sounds like more work, but in reality, people are used to taking pills (whether Rx or dietary supplement). It fits into routines more naturally.

There’s also cost to consider. While both options can be expensive, some of the oral versions are entering the market at lower price points, which may make them more accessible depending on your insurance.

So the “better” option isn’t always the one that performs best in a trial. It’s the one you can stick with.

What the Research Says About Effectiveness

Injectables still have the edge in terms of raw numbers. Studies on semaglutide and tirzepatide consistently show higher average weight loss compared to oral options. However, there are no direct head-to-head trials comparing the newest oral GLP-1s to injectables yet.

And some clinicians suspect that in the real world, oral medications could close that gap simply because they’re easier to take consistently. So while injectables may win in a controlled environment, the real-world “winner” is still up for debate.

Jenna’s Take On Oral vs Injectable GLP-1’s

I’m not anti–GLP-1. Let’s get that out of the way first. These medications can be incredibly helpful, especially for patients who feel like their hunger is running the show, whether that’s driven by blood sugar instability, hormonal shifts or emotional eating patterns.

But I also see the downsides.

When you blunt appetite this aggressively, you can unintentionally create new problems:

• People under-eat protein and lose muscle
• Micronutrient intake drops
• Energy tanks
• Digestion slows… sometimes too much. (There are at least 1,300 grouped federal gastroparesis lawsuits against GLP-1 manufacturers.)
• Other serious but less common side effects

But the bigger issue from a functional medicine perspective is that GLP-1s don’t fix the root cause. Neither do they balance stress hormones like cortisol or teach your body how to regulate hunger on its own.

Instead, they turn down the hunger volume. Sometimes, that’s exactly what we need, at least temporarily.

In my practice, I use GLP-1s strategically. Not as a forever solution, but as a tool within a bigger plan that includes:

• Lab testing to understand metabolic drivers
• Nutrition strategies that preserve muscle and nutrient status
• Targeted supplementation
• Lifestyle coaching that makes results sustainable

Because if you come off the medication and everything falls apart… we didn’t actually solve the problem.

Oral vs Injectable GLP-1’s: Which Wins?

If you’re looking purely at weight loss numbers, injectables still come out ahead. But if you’re looking at convenience and adherence, oral options are quickly catching up, and may even win for certain patients.

But the real answer isn’t “pill vs. shot.”

It’s whether the approach you choose fits your biology, your habits and your long-term plan.